Close Menu

NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Tuesday that its fourth quarter revenues rose nearly 500 percent year over year.

For the three months ended Dec. 31, the company's total revenues rose to $1.3 million from $218,283 in the prior-year quarter. Within its overall revenue, $1.2 million came from commercial testing and another $70,000 was from the firm's development services.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.